The trajectory of companies tied to flagship drugs like Viagra presents a challenging investment picture. While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial https://maciecokw870322.amoblog.com/sildenafil-and-its-maker-and-big-pharma-a-risky-investment-63273657